囊性肾细胞癌:回顾性影像识别患者的手术与主动监测结局
研究纳入2000至2015年138例影像上囊性成分>50%且病理确诊的囊性肾肿块患者,其中73.9%为肾细胞癌,良性占26.1%;另分析38例主动监测患者,总体生长率1.0 mm/年,实体成分2.3 mm/年,中位随访>4年无复发或转移。
要点
- 影像囊性成分>50%的囊性肾肿块中约四分之三为肾细胞癌。
- 多数肿瘤为低Fuhrman分级、pT2及以下和透明细胞组织学。
- 主动监测下总体生长率1.0 mm/年,实体成分2.3 mm/年。
核心结论
- 单灶囊性肾细胞癌在影像囊性成分>50%标准下,手术切除和主动监测预后均极好。
研究设计与样本
- 回顾性识别2000至2015年病理确诊的囊性肾肿块430例,排除缺乏CT、影像囊性<50%、多灶及既往肾癌后纳入138例分析。
- 另回顾性分析38例接受主动监测的囊性肾细胞癌患者。
主要发现
- 138例中102例(73.9%)为肾细胞癌,36例(26.1%)为良性肿块。
- 77.5%为Fuhrman 1-2级,83.4%为pT2或以下,65.9%为透明细胞组织学。
- 单因素分析中男性、实体成分和Bosniak分级升高与恶性显著相关。
- 主动监测队列总体生长率1.0 mm/年,实体成分2.3 mm/年。
- 所有队列中位随访>4年,无囊性肾细胞癌复发或转移证据。
临床怎么用
- 对影像囊性成分>50%的单灶囊性肾肿块,可考虑主动监测或手术切除,两者预后均良好。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the outcomes of surgical intervention and active surveillance in patients diagnosed with cystic renal cell carcinoma at our hypothesized radiological cutoff of greater than 50% cystic. MATERIALS AND METHODS: We identified all 430 patients with a pathologically confirmed cystic renal mass that fit our criteria from 2000 to 2015. The 292 patients with a lack of computerized tomography, tumors less than 50% cystic on imaging, multifocal tumors and prior renal cell carcinoma were excluded from study. Patients were stratified into benign or malignant subgroups, and radiological, clinicopathological and oncologic features were determined. Univariate and multivariate associations between clinicoradiological parameters in each group were analyzed. We similarly reviewed the records of a separate cohort of patients treated with active surveillance for cystic renal cell carcinoma. RESULTS: Of the 138 identified cases of cystic renal cell carcinoma 102 (73.9%) were renal cell carcinoma and 36 (26.1%) were benign masses. Of the tumors 77.5% were Fuhrman grade 1-2, 83.4% were stage pT2 or less and 65.9% showed clear cell histology. On univariate analysis male gender, a solid component and increasing Bosniak classification were significant for malignancy. In a separate cohort we identified 38 patients on active surveillance. The growth rate was 1.0 mm per year overall and 2.3 mm per year for the solid component. At a median followup of more than 4 years in all cohorts there was no evidence of recurrence or metastasis of cystic renal cell carcinoma. CONCLUSIONS: Patients with unifocal cystic renal cell carcinoma evaluated using a standardized radiological threshold of greater than 50% cystic had an excellent prognosis on active surveillance and after surgical resection.
引用
- Kashan M, Ghanaat M, Hötker AM, et al. Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging. J Urol. 2018. PMID: 29496470. doi:10.1016/j.juro.2018.02.3087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。